標題: Titlebook: Cell Therapy, Stem Cells and Brain Repair; Cyndy Davis Sanberg,Paul R. Sanberg Book 2007 Humana Press 2007 Activation.Nervous System.Parki [打印本頁] 作者: trace-mineral 時間: 2025-3-21 17:09
書目名稱Cell Therapy, Stem Cells and Brain Repair影響因子(影響力)
書目名稱Cell Therapy, Stem Cells and Brain Repair影響因子(影響力)學科排名
書目名稱Cell Therapy, Stem Cells and Brain Repair網絡公開度
書目名稱Cell Therapy, Stem Cells and Brain Repair網絡公開度學科排名
書目名稱Cell Therapy, Stem Cells and Brain Repair被引頻次
書目名稱Cell Therapy, Stem Cells and Brain Repair被引頻次學科排名
書目名稱Cell Therapy, Stem Cells and Brain Repair年度引用
書目名稱Cell Therapy, Stem Cells and Brain Repair年度引用學科排名
書目名稱Cell Therapy, Stem Cells and Brain Repair讀者反饋
書目名稱Cell Therapy, Stem Cells and Brain Repair讀者反饋學科排名
作者: buoyant 時間: 2025-3-21 20:18 作者: liaison 時間: 2025-3-22 04:16
https://doi.org/10.1007/BFb0048474ciated with the current regime using human fetal tissue, and an alternative cell source is therefore required. This chapter outlines the various cell sources that are being explored as possible alternatives for use in neural transplantation for HD.作者: 補充 時間: 2025-3-22 05:21
C. Rüchardt,Steric Effects,N. T. Anh brain microenvironment and NT2N cell grafts, laboratory research and clinical trials for the intracerebral transplantation of NT2N cells in stroke, the mechanisms underlying the grafts’ effects, and NT2N cell grafts and the need for immunosuppression. This chapter also highlights some of the most recent findings regarding NT2N cells.作者: CLAMP 時間: 2025-3-22 09:45
,Cell-Based Therapy for Huntington’s Disease,ciated with the current regime using human fetal tissue, and an alternative cell source is therefore required. This chapter outlines the various cell sources that are being explored as possible alternatives for use in neural transplantation for HD.作者: 主動 時間: 2025-3-22 13:51 作者: 主動 時間: 2025-3-22 19:13
Book 2007edicinal treatments for brain repair, many of these treatments and prescriptions lack adequate results or only have the ability to slow the p- gression of neurological disease or injury. Cell therapy, however, remains the most compelling treatment for neurodegenerative diseases, disorders, and injur作者: crucial 時間: 2025-3-22 21:39 作者: 種族被根除 時間: 2025-3-23 04:37
Hematopoietic Cell Therapy for Brain Repair,blood and summarize the recent literature on the use of these cells in experimental models of central nervous system injury and disease. We will discuss the neural potential of these hematopoietic cells and possible mechanisms underlying reported behavioral recovery.作者: morale 時間: 2025-3-23 06:24 作者: maudtin 時間: 2025-3-23 12:11
https://doi.org/10.1007/978-1-59745-147-5Activation; Nervous System; Parkinson; clinical application; inflammatory response作者: arthroscopy 時間: 2025-3-23 15:11
Cyndy Davis Sanberg,Paul R. SanbergIncludes supplementary material: 作者: Vo2-Max 時間: 2025-3-23 19:16
Contemporary Neurosciencehttp://image.papertrans.cn/c/image/222891.jpg作者: Parameter 時間: 2025-3-23 23:18
Optimization of Discrete Time Systemsntirely different perspective (.–.). We have learned that there is a n inborn lasticity anThe Burnham Institute,,La Jolla,CAd flexibility “programmed” into the organism and its organ systems (.). The repository of this plasticity is thought to be the stem cell—the most primordial cell in the body an作者: 絕食 時間: 2025-3-24 04:44
Hans Günter Aurich,Wolfram Weissisease (PD) and, in some cases, have successfully restored function. However, there are insufficient numbers of cells available to allow this therapy to become widely used. The limited amount of tissue from embryos may be circumvented by the use of cell lines that can be expanded in vitro for bankin作者: impale 時間: 2025-3-24 09:32 作者: 鋼盔 時間: 2025-3-24 12:52 作者: 吹氣 時間: 2025-3-24 18:16 作者: CRUE 時間: 2025-3-24 22:21
C. Rüchardt,Steric Effects,N. T. Anhn from laboratories to clinical settings. Procurement logistics and novel neuroprotective functions associated with these cells allow their use to serve as an efficacious alternative to the use of fetal cells as donor cell grafts for stroke therapy. However, the optimal transplantation regimen must 作者: 做作 時間: 2025-3-25 03:14
https://doi.org/10.1007/BFb0048834inductive cues. In the past hematopoietic stem cells were identified in bone marrow that have the capability to differentiate into cells that are part of the blood system. The cells therefore are restricted to the types of cells they can become. Recently, other types of stem cells such as mesenchyma作者: Allergic 時間: 2025-3-25 03:25
Computational methods of correlation energy,ury (TBI). As the goals of these two therapeutic targets are widely disparate, approaches have evolved along distinctive paths. Thus, although the provision of a local cellular source of pharmacologic analgesic molecules may be most appropriate in the management of chronic pain, central nervous syst作者: NICHE 時間: 2025-3-25 09:33 作者: 窗簾等 時間: 2025-3-25 14:39
https://doi.org/10.1007/BFb0050135CP been implicated in other basic aspects of neural functioning, such as surveying the chemical and immunological status of the brain, detoxifying the brain, secreting a nutritive cocktail of polypeptides for neuronal function and survival, and participating in repair processes following trauma. The作者: 不滿分子 時間: 2025-3-25 17:55 作者: 喊叫 時間: 2025-3-25 23:30
N-methylacetamide as a solvent,herapy for brain repair. Recently, commentators suggested that the need for rapid scientific and commercial successes has privileged approaches, which are inadequate for solving the problems inherent in the project of repairing the human brain. Critical analysis of recent clinical trials for the tre作者: 概觀 時間: 2025-3-26 03:59
https://doi.org/10.1007/BFb0050143alternative cell sources imperative for stem cell researchers. Bone marrow and umbilical cord blood both harbor a population of stem cells and transplantation studies in multiple models of brain injury and disease have demonstrated proof of principle for these cells as possible therapeutics. In this作者: pus840 時間: 2025-3-26 05:22
https://doi.org/10.1007/BFb0050697 treating degenerative disease, and the influence in health care costs for the elderly population, has become more apparent (.). It is also clear that tissue implant use fails, as the majority of implants do not integrate within the host tissue, die, or are no longer available after a period of time作者: 簡略 時間: 2025-3-26 11:16 作者: 交響樂 時間: 2025-3-26 16:19
,Developing Novel Cell Sources for Transplantation in Parkinson’s Disease,isease (PD) and, in some cases, have successfully restored function. However, there are insufficient numbers of cells available to allow this therapy to become widely used. The limited amount of tissue from embryos may be circumvented by the use of cell lines that can be expanded in vitro for bankin作者: STEER 時間: 2025-3-26 20:49 作者: 冷淡一切 時間: 2025-3-26 22:54
,Cell-Based Therapy for Huntington’s Disease,he disease manifests in the third and fourth decades of life, and death is imminent usually within 20 yr. Its pathology is marked by cell loss in the striatal nuclei. Following the marked cell loss, enlargement of the ventricles is observed, as well as cortical degeneration. The aim of neural transp作者: GEN 時間: 2025-3-27 01:10
,Use of Bone Marrow Stem Cells as Therapy for Behavioral Deficits in Rodent Models of Huntington’s Den the donor and recipient are different individuals) transplants of adult, bone-marrow-derived stem cells to counteract the behavioral deficits produced by intrastriatal injections of quinolinic acid (QA) in rats, a rodent model for Huntington’s disease (.). These studies support previous findings 作者: 清晰 時間: 2025-3-27 08:52 作者: 華而不實 時間: 2025-3-27 10:03
Therapeutic Applications of Bone Marrow-Derived Stem Cells in Neurologic Injury and Disease,inductive cues. In the past hematopoietic stem cells were identified in bone marrow that have the capability to differentiate into cells that are part of the blood system. The cells therefore are restricted to the types of cells they can become. Recently, other types of stem cells such as mesenchyma作者: 拖網 時間: 2025-3-27 16:43
Cell Therapy for Models of Pain and Traumatic Brain Injury,ury (TBI). As the goals of these two therapeutic targets are widely disparate, approaches have evolved along distinctive paths. Thus, although the provision of a local cellular source of pharmacologic analgesic molecules may be most appropriate in the management of chronic pain, central nervous syst作者: cliche 時間: 2025-3-27 20:53
The Use of Sertoli Cells in Neural Transplantation,uitable donor tissue necessitates the development of novel approaches to enable transplantation on a widespread basis. Transplantable cells obtained from xenogeneic sources have shown considerable promise in preclinical animal models, as well as in a limited number of human trials conducted to date.作者: 無法治愈 時間: 2025-3-27 22:49
The Choroid Plexus,CP been implicated in other basic aspects of neural functioning, such as surveying the chemical and immunological status of the brain, detoxifying the brain, secreting a nutritive cocktail of polypeptides for neuronal function and survival, and participating in repair processes following trauma. The作者: 羅盤 時間: 2025-3-28 05:58
Progress and Challenges in Immunoisolation for CNS Cell Therapy,ature to the brain parenchyma. One method to overcome the BBB is with cellular implants that produce and deliver therapeutic molecules directly to the brain region of interest. Immunoisolation is based on the observation that xenogeneic cells can be protected from host rejection by encapsulating, or作者: 陳舊 時間: 2025-3-28 08:37 作者: receptors 時間: 2025-3-28 14:17 作者: Palpitation 時間: 2025-3-28 17:25 作者: Felicitous 時間: 2025-3-28 18:50 作者: HAWK 時間: 2025-3-29 00:33 作者: 我不怕犧牲 時間: 2025-3-29 04:02 作者: 誘使 時間: 2025-3-29 08:28
C. Rüchardt,Steric Effects,N. T. Anho transdifferentiate into neurons. However, because less than 1% of the cells expressed neuronal phenotypes, and because the functional recovery observed in all three studies occurred within 1 mo after transplantation, it is hypothesized that the ameliorative effects of the transplants were due to t作者: Concerto 時間: 2025-3-29 12:02
Computational methods of correlation energy,lation, implantable mechanical pumps, and a myriad of drugs for pain relief, but cell and molecular technologies are a new frontier in pain medicine..The earliest cell therapy studies for pain relief tested adrenal chromaffin cells from rat or bovine sources that were placed in the subarachnoid spac作者: anesthesia 時間: 2025-3-29 15:47 作者: Obstruction 時間: 2025-3-29 22:26
https://doi.org/10.1007/BFb0050135ir processes following trauma. CP dysfunction in central nervous system (CNS) diseases, and the endogenous secretion of growth factors, indicates that transplantable CP might enable delivery of growth factors to the brain while avoiding the conventional molecular and genetic alterations associated w作者: armistice 時間: 2025-3-30 02:09
https://doi.org/10.1007/BFb0050135uman sources. This chapter discusses cell immunoisolation for treating central nervous system (CNS) diseases, from concept to preclinical evaluation, in a wide range of animal models and relating to the clinical trials conducted to date.作者: Facet-Joints 時間: 2025-3-30 05:37 作者: 憤慨一下 時間: 2025-3-30 10:22 作者: Fatten 時間: 2025-3-30 12:53 作者: JADED 時間: 2025-3-30 19:42
,Developing Novel Cell Sources for Transplantation in Parkinson’s Disease,ces therapeutically for PD. The primary reasons are because it has not been feasible to effectively differentiate these cells into DAergic neurons and because the stability of phenotypic expression has been variable. This chapter describes methods to generate cells suitable for transplantation in PD
